4
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Exudative and Absorptive Permeability in Different Phases of an Experimental Colitis Condition

, &
Pages 900-905 | Received 20 Dec 1995, Accepted 10 Apr 1996, Published online: 08 Jul 2009

References

  • Wallace J L. 5‐Lipoxygenase: a rational target for therapy on inflammatory bowel disease?. Trends Pharmacol Sci 1990; 11: 51–3
  • Hollander D, Vadheim C M, Brettholz E, Petersen G, Delahunty T, Rotter J. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986; 105: 883–5
  • Katz K D, Hollander D, Vadheim C D, McElree C, Delahunty T, Dadufalza V D, et al
  • Teahon K, Smethhurst P, Levi A J, Menzies I S, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992; 33: 320–3
  • Ruttenberg D, Young G O, Wright J P, Isaacs S. PEG‐400 excretion in patients with Crohn's disease, their first‐degree relatives, and healthy volunteers. Dig Dis Sci 1992; 37: 705–8
  • Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz K D, et al. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994; 35: 68–72
  • Gustafsson B, Persson C GA. Allergen‐induced mucosal exudation of plasma into rat ileum and its inhibition by budesonide. Scand J Gastroenterol 1992; 27: 587–93
  • Persson C GA, Gustafsson B, Erjefält J S, Sundler F. Mucosal exudation of plasma is a noninjurious intestinal defense mechanism. Allergy 1993; 48: 581–6
  • Waldmann T A. Gastrointestinal protein loss demonstrated by 51Cr‐labelled albumin. Lancet 1961; 2: 121–3
  • Beeken W L, Busch H J, Sylwester D L. Intestinal protein loss in Crohn's disease. Gastroenterology 1972; 62: 207–15
  • Karbach U, Ewe K, Bodenstein J. Alpha1‐antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 1983; 24: 718–23
  • Meyers S, Wolke A, Field S P, Feuer E J, Johnson J W, Janowitz H D. Fecal α1‐antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology 1985; 89: 13–8
  • Ferguson A, Ghosh S, Harny L M, Choudari C, Mwantembe O, McIntyre M A. Analysis of disease distribution, activity and complications in the patient with inflammatory bowel disease. Scand J Gastroenterol 1994; 29(Suppl 203)15–9
  • Persson C GA. Airway epithelium and microcirculation. Eur Respire Rev 1994; 23: 352–62
  • Fabia R, Ar'Rajab A, Willén R, Brattsand R, Erlansson M, Svensjö E. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid‐induced acute colitis in the rat. Aliment Pharmacol Ther 1994; 8: 433–46
  • Fabia R, Willén R, Ar'Rajab A, Andersson R, Ahrén B, Bengmark S. Acetic acid induced colitis in the rat. A reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992; 24: 211–25
  • Bradley P P, Priebat D A, Christensen R D, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with a enzyme marker. J Invest Derm 1982; 78: 206–9
  • Krawisz J E, Sharon P, Stenson W F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984; 87: 1344–50
  • Persson C GA, Gustafsson B. Absorption and exudation‐permeability across the gut mucosa in vivo. Differential actions of allergen and acetic acid. Gastroenterology 1994; 4: A752
  • Bell C J, Gall D G, Wallace J L. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 1995; 268: G622–30
  • Riegler M, Feil W, Lindroth J, Wong M. Real‐time morphometry to quantify the time course of rapid epithelial restitution. Pathol Res Pract 1992; 188: 443–8
  • Allen R N. Clinical Presentation (Crohn's Disease). Gastroenterology clinical science and practice. Chapter 7. Inflammatory bowel disease2nd ed., I AD Boucher, R N Allen, H JF Hodgson, M RB Keighley. Saunders, London 1993; Vol 2: 1134
  • Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi G A. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986; 91: 1490–4
  • Persson C GA, Andersson M, Greiff L, Svensson C, Erjefält J S, Sundler F, et al. Airway permeability. Clin Exp Allergy 1995; 23: 807–14
  • Gustafsson B, Persson C GA. Asymmetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. A study in guinea‐pig tracheal tube preparation. Clin Exp Allergy 1991; 21: 121–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.